Futurism: Fate of Male Birth Control Injection Now in Government’s Hands

760

After concluding numerous clinical trials, the Indian Council of Medical Research announces the successful production of a male contraceptive injection. The trials found that the contraceptive has a 97.3% success rate with no reported side effects and effectiveness of 13 years. The polymer is injected into the vas deferens and prevents sperm from leaving the testicles. The product is awaiting regulatory approval before the manufacturing process can begin. Read the full article here.

Comments are closed.

Skip to toolbar